Call to arms as UK falls back in medicines manufacturing
Pharma Phorum
JANUARY 24, 2023
Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition.
Pharma Phorum
JANUARY 24, 2023
Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition.
PharmaVoice
JANUARY 24, 2023
A longtime leader in the respiratory space, AstraZeneca has hammered another stake in the ground with its newest asthma treatment, Airsupra
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Phorum
JANUARY 24, 2023
In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.
InCrowd
JANUARY 24, 2023
In November of 2022, InCrowd surveyed 500 US physicians to track burnout. In 2022, reports showed that physician burnout had risen to frightening levels.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.
Pharma Phorum
JANUARY 24, 2023
Drug development has long been an issue for the pharma industry, due to the expense and the high failure rate of potential treatments. Ben Hargreaves finds that the vast amount of genetic data that exists today could help provide a faster, more targeted way of developing new drug candidates.
Outsourcing Pharma
JANUARY 24, 2023
Research emerging from the University of Toronto found that using machine learning models was able to guide the design of long-acting drug formulations. Clinical Development
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
JANUARY 24, 2023
Hospital, health system boards saw low turnover, slow diversity gains from 2018-2022, AHA finds dmuoio Tue, 01/24/2023 - 10:23
European Pharmaceutical Review
JANUARY 24, 2023
Velocity Clinical Research , the largest integrated research site organisation globally, has made three all-female key leadership hires. This move strengthens its European senior executive team as the firm continues its expansion in the region.
Fierce Healthcare
JANUARY 24, 2023
With the X-waiver repealed, officials urge providers to begin prescribing buprenorphine for opioid addiction dmuoio Tue, 01/24/2023 - 14:52
Fierce Pharma
JANUARY 24, 2023
Bristol Myers doubles down in immuno-oncology patent fight with AZ, this time targeting Imjudo fkansteiner Tue, 01/24/2023 - 16:13
Fierce Healthcare
JANUARY 24, 2023
Blues to press Congress to expand site-neutral payment reforms to more outpatient clinics rking Tue, 01/24/2023 - 11:30
Pharma Phorum
JANUARY 24, 2023
Efforts by Amazon to disrupt the healthcare sector just stepped up a gear, with the launch of a subscription service for Prime members that will ship generic medicines to patients’ homes in return for a $5 monthly fee.
Fierce Healthcare
JANUARY 24, 2023
Industry Voices—Key to rural hospital survival: Sustainable solutions for patient financial engagement hlandi Tue, 01/24/2023 - 09:47
Pharmaceutical Technology
JANUARY 24, 2023
The US Food and Drug Administration (FDA) has granted clearance for Neurogene’s investigational new drug (IND) application for NGN-401 to treat Rett syndrome.
Fierce Healthcare
JANUARY 24, 2023
Providers jostle to lead way if FDA makes COVID vaccination a yearly jab fdiamond Tue, 01/24/2023 - 08:46
Fierce Pharma
JANUARY 24, 2023
Bayer’s oncology business looks to collect $10B in sales by 2030, exec says zbecker Tue, 01/24/2023 - 09:14
Fierce Healthcare
JANUARY 24, 2023
Managed care plans, states can now text Medicaid beneficiaries to warn of enrollment changes rking Tue, 01/24/2023 - 13:59
Fierce Pharma
JANUARY 24, 2023
Georgia Tech spinout bags cash for nucleic acid delivery R&D ntaylor Tue, 01/24/2023 - 10:10
PharmExec
JANUARY 24, 2023
Readily available real-world data and advanced solutions are being used to stitch together the full patient journey, and these longitudinal insights are being used to identify and characterize trial populations and inform clinical trial design and execution strategies.
Fierce Pharma
JANUARY 24, 2023
Advancing node-to-brain delivery, team treats stoke in rodents using intranasal antibody ntaylor Tue, 01/24/2023 - 05:45
Pharmaceutical Commerce
JANUARY 24, 2023
Transaction expected to close early this year us
Pharma Mirror
JANUARY 24, 2023
Science-based innovation for manufacturing high quality cells challenges dogma and terminology Cell and gene therapies are dominating the world of drug development.
InCrowd
JANUARY 24, 2023
In November of 2022, InCrowd surveyed 500 US physicians to track burnout. Download the full report to learn more about this research. The post Physician Opinions on Burnout in 2022 – Report appeared first on InCrowd. Report
Pharmafile
JANUARY 24, 2023
Advocacy group, the Physicians Committee for Responsible Medicine, has accused Novo Nordisk of breaching FDA’s Fair Balance policy after Novo Nordisk’s weight loss drug Wegovy appeared on CBS’s 60 Minutes news segment about obesity. read more Sales and Marketing
Pharmaceutical Commerce
JANUARY 24, 2023
Reflects company’s identity and pharma supply chain impact us
Pharmafile
JANUARY 24, 2023
TheracosBio has announced that the first oral SGLT2 inhibitor, bexaflilozin, has been approved by the FDA for the treatment of adult patients with type 2 diabetes. The drug was originally indicated for cats with diabetes.
PharmaVoice
JANUARY 24, 2023
Data discrepancies between study phases and indications could provide clues about why some trials have better racial and ethnic diversity than others
Pharmafile
JANUARY 24, 2023
WHO has released an urgent “call to action” to all 194 WHO member states in order to try and prevent, detect and respond to incidences of illegitimate medical products.
Fuld
JANUARY 24, 2023
BOSTON – Jan 24, 2023 – Fuld & Company, a fast-growing research, analytics, and advisory business, today announced the appointment of Charles Collier to the role of Senior Vice President, Consulting Research & Analytics.
Pharmafile
JANUARY 24, 2023
With respiratory infections increasing, an ongoing cost of living crisis and the Russia-Ukraine conflict, officials throughout Europe are beginning to look into contingency plans to deal with the concerning shortages of certain antibiotics.
Pharma Phorum
JANUARY 24, 2023
With a separation from parent company Novartis now confirmed, Sandoz has moved to strengthen its revenue base with the acquisition of global rights to mainstay antifungal drug Mycamine from Japan’s Astellas.
Pharma Phorum
JANUARY 24, 2023
Tech company CytoReason has announced it has signed a multi-year, multimillion dollar deal with Sanofi to deliver artificial intelligence (AI) for drug discovery and development in the field of inflammatory bowel disease (IBD).
Pharmafile
JANUARY 24, 2023
Published date: 24/01/2023 Summary: London, 24th January - finnCap Cavendish, part of finnCap Group plc, is pleased to announce it has advised on the sale of Therapy Equipment Limited to ESAB Corporation. Founded in 1983, Therapy Equipment Ltd.
Fierce Pharma
JANUARY 24, 2023
Eyeing tissue targeting, AstraZeneca consortium gets cash for nucleic acid delivery work ntaylor Tue, 01/24/2023 - 05:42
Let's personalize your content